TLT Theralase Technologies Inc.

0.1800CAD+2.86%Mkt Cap: 40.70M $P/E: —

Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research, development, and commercialization of energy activated small molecules and associated drug formulations in Canada, the United…

Key Statistics

Company
Market Cap40.70M USD
Enterprise Value35.85M USD
Revenue (TTM)584.40K USD
Gross Profit369.32K USD
Net Income (TTM)-3.00M USD
Revenue/Share0.0030 CAD
Last Price0.1800 CAD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryCA
SectorHealthcare
IndustryMedical Devices
ISINCA88337V1004
Valuation
P/E (Trailing)—
P/E (Forward)-17.50
PEG—
EV/EBITDA-13.48
EV/Revenue61.34
P/S67.71
P/B7.61
EPS (TTM)-0.01
EPS (Forward)-0.01
52W Range
0.150012% of range0.4100
52W High0.4100 CAD
52W Low0.1500 CAD
Profitability
Gross Margin62.11%
Oper. Margin-647.24%
EBITDA Margin0.00%
Profit Margin-504.71%
ROE-231.79%
ROA-117.92%
Growth
Revenue Growth-25.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.39M USD
CapEx (TTM)35.64K USD
FCF Margin-277.41%
FCF Yield-3.98%
Net Debt-3.72M USD
Net Debt/EBITDA1.40
Balance Sheet
Debt/Equity0.26
Current Ratio5.48
Quick Ratio4.89
Book Value/Sh0.02 CAD
Cash/Share0.02 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)0.7000 CAD
Upside (mean)+288.9%
Target Range0.7000 CAD – 0.7000 CAD
# Analysts1
Ownership
Shares Out.310.48M
Float291.33M
Insiders8.45%
Institutions0.00%
Short Interest
Short Ratio0.7d
Short % Out.0.07%
Shares Short209.60K
Short (prev mo.)20.30K
Technical
SMA 500.2018 (-10.8%)
SMA 2000.2473 (-27.2%)
Beta0.41
S&P 52W Chg16.45%
Avg Vol (30d)202.61K
Avg Vol (10d)88.00K
Technical Indicators
RSI (14)43.9
MACD-0.0074
MACD Signal-0.0095
MACD Hist.+0.0021
BB Upper0.1916 CAD
BB Middle0.1810 CAD
BB Lower0.1704 CAD
BB Width11.67%
ATR (14)0.0098 CAD
Vol Ratio (20d)0.19x